# Gladstone Investment Corporation\\de: financial statements, quarterly

GAIN · Nasdaq · CIK 1321741 · [Other](/sectors/other.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/gain.md) · [Financials](/companies/gain/financials.md) · [Filings](/companies/gain/filings.md) · [Insiders](/companies/gain/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gain/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [47.4](/filings/0001321741-24-000017.md) | [6.6](/filings/0001321741-25-000005.md) | [22.6 d](/filings/0001321741-26-000011.md) | [(6.5)](/filings/0001321741-25-000018.md) | [15.5](/filings/0001321741-25-000022.md) | [38.5](/filings/0001321741-26-000005.md) | [17.9 d](/filings/0001321741-26-000011.md) | [7.8](/filings/0001321741-26-000017.md) | [28.7](/filings/0001321741-25-000022.md) | [65.9](/filings/0001321741-26-000005.md) | [82.4 d](/filings/0001321741-26-000011.md) | [(11.9)](/filings/0001321741-26-000017.md) |
| Diluted EPS | $ per share | [(0.05)](/filings/0001321741-24-000017.md) | [0.28](/filings/0001321741-25-000005.md) | not reported | [0.34](/filings/0001321741-24-000013.md) | [0.20](/filings/0001321741-24-000017.md) | [0.03](/filings/0001321741-25-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.05)](/filings/0001321741-24-000017.md) | [0.28](/filings/0001321741-25-000005.md) | not reported | [0.34](/filings/0001321741-24-000013.md) | [0.20](/filings/0001321741-24-000017.md) | [0.03](/filings/0001321741-25-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.1](/filings/0001321741-23-000026.md) | [2.8](/filings/0001321741-24-000005.md) | [2.5](/filings/0001321741-25-000010.md) | [2.4](/filings/0001321741-24-000013.md) | [2.0](/filings/0001321741-24-000017.md) | [2.6](/filings/0001321741-25-000005.md) | [14.3](/filings/0001321741-25-000018.md) | [4.1](/filings/0001321741-25-000018.md) | [0.2](/filings/0001321741-25-000022.md) | [1.4](/filings/0001321741-26-000005.md) | [1.1](/filings/0001321741-26-000017.md) | [1.6](/filings/0001321741-26-000017.md) |
| Total assets | $m | [928](/filings/0001321741-23-000026.md) | [918](/filings/0001321741-24-000005.md) | [938](/filings/0001321741-25-000010.md) | [914](/filings/0001321741-24-000013.md) | [869](/filings/0001321741-24-000017.md) | [1,088](/filings/0001321741-25-000005.md) | [1,006](/filings/0001321741-26-000011.md) | [1,054](/filings/0001321741-25-000018.md) | [1,144](/filings/0001321741-25-000022.md) | [1,237](/filings/0001321741-26-000005.md) | [1,323](/filings/0001321741-26-000017.md) | [1,303](/filings/0001321741-26-000017.md) |
| Total liabilities | $m | [453](/filings/0001321741-23-000026.md) | [458](/filings/0001321741-24-000005.md) | [445](/filings/0001321741-25-000010.md) | [437](/filings/0001321741-24-000013.md) | [410](/filings/0001321741-24-000017.md) | [598](/filings/0001321741-25-000005.md) | [507](/filings/0001321741-26-000011.md) | [569](/filings/0001321741-25-000018.md) | [609](/filings/0001321741-25-000022.md) | [641](/filings/0001321741-26-000005.md) | [655](/filings/0001321741-26-000017.md) | [656](/filings/0001321741-26-000017.md) |
| Long-term debt | $m | [410](/filings/0001321741-23-000026.md) | [414](/filings/0001321741-24-000005.md) | [398](/filings/0001321741-25-000010.md) | [395](/filings/0001321741-24-000013.md) | [341](/filings/0001321741-24-000017.md) | [547](/filings/0001321741-25-000005.md) | [456](/filings/0001321741-26-000011.md) | [519](/filings/0001321741-25-000018.md) | [555](/filings/0001321741-25-000022.md) | [572](/filings/0001321741-26-000005.md) | [564](/filings/0001321741-26-000017.md) | [571](/filings/0001321741-26-000017.md) |
| Shareholders' equity | $m | [476](/filings/0001321741-25-000005.md) | [460](/filings/0001321741-25-000005.md) | [493](/filings/0001321741-26-000011.md) | [477](/filings/0001321741-26-000005.md) | [458](/filings/0001321741-26-000005.md) | [490](/filings/0001321741-26-000005.md) | [499](/filings/0001321741-26-000017.md) | [485](/filings/0001321741-26-000017.md) | [536](/filings/0001321741-26-000005.md) | [595](/filings/0001321741-26-000005.md) | [668](/filings/0001321741-26-000017.md) | [647](/filings/0001321741-26-000017.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(60.1) d](/filings/0001321741-24-000017.md) | [20.9 d](/filings/0001321741-25-000005.md) | [5.8 d](/filings/0001321741-26-000011.md) | [12.3](/filings/0001321741-25-000018.md) | [63.2 d](/filings/0001321741-25-000022.md) | [(172) d](/filings/0001321741-26-000005.md) | [113 d](/filings/0001321741-26-000011.md) | [(50.2)](/filings/0001321741-26-000017.md) | [(60.7) d](/filings/0001321741-25-000022.md) | [(7.6) d](/filings/0001321741-26-000005.md) | [16.8 d](/filings/0001321741-26-000011.md) | [8.1](/filings/0001321741-26-000017.md) |
| Dividends paid | $m | [12.2 d](/filings/0001321741-24-000017.md) | [43.1 d](/filings/0001321741-25-000005.md) | [8.7 d](/filings/0001321741-26-000011.md) | [8.8](/filings/0001321741-25-000018.md) | [8.8 d](/filings/0001321741-25-000022.md) | [34.5 d](/filings/0001321741-26-000005.md) | [8.8 d](/filings/0001321741-26-000011.md) | [28.8](/filings/0001321741-26-000017.md) | [9.3 d](/filings/0001321741-25-000022.md) | [9.5 d](/filings/0001321741-26-000005.md) | [9.6 d](/filings/0001321741-26-000011.md) | [9.6](/filings/0001321741-26-000017.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.2](/filings/0001321741-23-000026.md) | [33.3](/filings/0001321741-24-000005.md) | [33.6](/filings/0001321741-24-000013.md) | [33.8](/filings/0001321741-24-000017.md) | [34.4](/filings/0001321741-25-000005.md) | [36.7](/filings/0001321741-25-000018.md) | [36.7](/filings/0001321741-25-000022.md) | [36.7](/filings/0001321741-26-000005.md) | [36.9](/filings/0001321741-26-000017.md) | [38.4](/filings/0001321741-25-000022.md) | [39.7](/filings/0001321741-26-000005.md) | [39.8](/filings/0001321741-26-000017.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 39,821,967 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0001321741-26-000017.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.